Search Results 571-580 of 1875 for 免费ai写歌网站,ai一键修图网站,ai门户网站,ai工具集官网,ai企业官网,等欢迎访问豌豆Ai站群搜索引擎系统官方网站:www.wd.chat

1. A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Isatuximab in Patients With Multiple Myeloma - Mayo Clinic

   About this study. Primary Objective: - Part A: To evaluate the safety of SAR650984 (isatuximab) in patients with relapsed/refractory multiple myeloma (RRMM) ...

2. A Biobank for Bipolar Disorder, by Mayo Clinic Individualized Medicine

   About this study. The purpose of this biobank is to develop a research resource for bipolar disorder. Patients, and close genetic relatives, will provide ...

3. A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

   A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic ...

4. Allo vs Hypomethylating/Best Supportive Care in MDS (BMT CTN 1102) - Mayo Clinic

   Arm 1: Reduced intensity conditioning allogeneic hematopoietic cell transplantation (RIC-alloHCT),. Arm 2: Non-Transplant Therapy/Best Supportive Care.

5. Young-adult normal FDG-PET database - Clinical Trials

   About this study. The purpose of this study is to construct a young-adult normative FDG database that could be used with Cortex-ID and/or MIMneuro, ...

6. Pediatric Extracranial Solid Tumor Biorepository - Mayo Clinic

   About this study. The purpose of this study is to create a biospecimen repository for both fresh frozen tissue from core needle biopsies and tumor ...

7. Phase 1/2 Study of AG-221 in Subjects With Advanced Hematologic Malignancies With an IDH2 Mutation - Mayo Clinic

   The study includes a dose escalation phase to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) and an expansion phase to ...

8. A Study Comparing Temozolomide and Selumetinib for Treating Patients with Metastatic Melanoma of the Eye - Mayo Clinic

   Selumetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet known whether temozolomide is more ...

9. Licensed technology - Biliary Epigenetics and Regenerative Medicine: Robert C. Huebert

   The Biliary Epigenetics and Regenerative Medicine Lab of Robert C. Huebert, M.D., at Mayo Clinic has developed a transformed sinusoidal endothelial cell ...

10. A Study to Evaluate Chemotherapy-Induced Nausea in Breast Cancer Patients - Mayo Clinic

    The long-term goal of this study is to alleviate the occurrence of CIN and fatigue and to improve chemotherapy treatment outcomes. The identification of ...